Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets

F Shu, H **ao, QN Li, XS Ren, ZG Liu, BW Hu… - … and Targeted Therapy, 2023 - nature.com
Autophagy is a conserved lysosomal degradation pathway where cellular components are
dynamically degraded and re-processed to maintain physical homeostasis. However, the …

Epigenetic regulation of angiogenesis in development and tumors progression: potential implications for cancer treatment

VM Aspriţoiu, I Stoica, C Bleotu… - Frontiers in cell and …, 2021 - frontiersin.org
Angiogenesis is a multi-stage process of new blood vessel development from pre-existing
vessels toward an angiogenic stimulus. The process is essential for tissue maintenance and …

Targeting histone modifications in breast cancer: a precise weapon on the way

W Li, H Wu, S Sui, Q Wang, S Xu… - Frontiers in cell and …, 2021 - frontiersin.org
Histone modifications (HMs) contribute to maintaining genomic stability, transcription, DNA
repair, and modulating chromatin in cancer cells. Furthermore, HMs are dynamic and …

Perspectives on the role of histone modification in breast cancer progression and the advanced technological tools to study epigenetic determinants of metastasis

J Zhuang, Q Huo, F Yang, N **e - Frontiers in Genetics, 2020 - frontiersin.org
Metastasis is a complex process that involved in various genetic and epigenetic alterations
during the progression of breast cancer. Recent evidences have indicated that the mutation …

Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury

J Tang, Y Shi, N Liu, L Xu, X Zang, P Li, J Zhang… - Clinical …, 2018 - portlandpress.com
Histone deacetylase 6 (HDAC6) has been shown to be involved in various pathological
conditions, including cancer, neurodegenerative disorders and inflammatory diseases …

HDAC6 inhibition promotes transcription factor EB activation and is protective in experimental kidney disease

AS Brijmohan, SN Batchu, S Majumder… - Frontiers in …, 2018 - frontiersin.org
To contend with the deleterious effects of accumulating misfolded protein aggregates or
damaged organelles cells rely on a system of quality control processes, among them the …

Epigenetic control of autophagy in cancer cells: a key process for cancer-related phenotypes

P Peixoto, C Grandvallet, JP Feugeas, M Guittaut… - Cells, 2019 - mdpi.com
Although autophagy is a well-known and extensively described cell pathway, numerous
studies have been recently interested in studying the importance of its regulation at different …

Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond

J Feng, X Meng - Frontiers in Pharmacology, 2022 - frontiersin.org
Dysregulated epigenetic enzymes and resultant abnormal epigenetic modifications (EMs)
have been suggested to be closely related to tumor occurrence and progression. Histone …

[HTML][HTML] β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells

D Mikami, M Kobayashi, J Uwada, T Yazawa… - Journal of …, 2020 - Elsevier
Ketone bodies, including acetoacetate and β-hydroxybutyrate (βOHB), are produced from
acetyl coenzyme A in the liver and then secreted into the blood. These molecules are a …

Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption

Y Wang, Y Zhou, Z Zheng, J Li, Y Yan, W Wu - Cell death & disease, 2018 - nature.com
Long treatment with paclitaxel (PTX) might increase resistance and side-effects causing a
failure in cancer chemotherapy. Here we uncovered that either sulforaphane-cysteine (SFN …